All In Biotech

NDA 020577 · Lukare Medical LLC

Elliotts B Solution

Calcium Chloride, Dextrose, Magnesium Sulfate, Potassium Chloride, Sodium Bicarbonate, Sodium Chloride, Sodium Phosphate, Dibasic, Heptahydrate · Intrathecal

Priority reviewOrphan

Last checked: Nov 19, 2026Latest source record: Nov 29, 2016 (newest FDA action)Source: Drugs@FDA, openFDA, CMS, ClinicalTrials.gov, PubMedMethods & limitations

First approved

1996

Sep 27, 1996

Approved uses

1

Original approval plus efficacy supplements

Registered trials

9,299

2,122 Phase 3, 968 recruiting

FAERS reports

0

0 serious, 0 with death reported

AI brief across all sources

Written by AI from the FDA, CMS, ClinicalTrials.gov, FAERS and PubMed data on this page, plus web searches for pricing, exclusivity and pending FDA decisions.

What it is approved for

From the label in effect Oct 16, 2024.

INDICATIONS AND USAGE Elliotts B Solution is indicated as a diluent for the intrathecal administration of methotrexate sodium and cytarabine for the prevention or treatment of meningeal leukemia or lymphocytic lymphoma.

Approval history

Original approval and efficacy supplements (new uses, populations or doses), newest first, with FDA's letters and labels.

  • Sep 27, 1996 Original approval · Type 3 - New Dosage Form · priority review
1 products under this application
  • ELLIOTTS B SOLUTION · CALCIUM CHLORIDE 0.2MG/ML; DEXTROSE 0.8MG/ML; MAGNESIUM SULFATE 0.3MG/ML; POTASSIUM CHLORIDE 0.3MG/ML; SODIUM BICARBONATE 1.9MG/ML; SODIUM CHLORIDE 7.3MG/ML; SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE 0.2MG/ML · INJECTABLE, INTRATHECAL · Prescription

Clinical trials

Interventional ClinicalTrials.gov studies with "Chloride" as an intervention, any sponsor and status, largest first.

All 9,299 trials

Most reported adverse reactions

FAERS reports naming this application or brand. Unverified reports, not rates; a report can name several drugs.

Signals

No FAERS reports name this application.

FAERS reports by year

By the date FDA received the report.

No reports.

Recalls

0 FDA enforcement reports for this application.

No recalls on record for this application.

Shortages

FDA's drug shortage list.

Not on FDA's shortage list.

Medicare spending

CMS Spending by Drug. Part D is pharmacy-dispensed; Part B is given in a clinic or hospital outpatient setting. Spending is before manufacturer rebates.

Compare

Not found under this brand name in Medicare's Part D or Part B Spending by Drug data. CMS lists some drugs under the generic name only.

Published evidence

PubMed clinical trials, meta-analyses and systematic reviews, most relevant first.

All 4,091 on PubMed

Sponsor: Lukare Medical LLC

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.